Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Isamu Tachibana, Sean Q. Kern, Antoin Douglawi, et al. Primary Retroperitoneal Lymph Node Dissection for Patients with Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary? J Clin Oncol. In press. https://doi.org/10.1200/JCO.22.00118: Is Retroperitoneal Lymph Node Dissection Without Adjuvant Chemotherapy Enough for All Patients with Pathologic Stage II Nonseminoma Germ Cell Tumor?

Eur Urol. 2023 Jan;83(1):e20-e21. doi: 10.1016/j.eururo.2022.09.018. Epub 2022 Oct 1.

¹ Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA. Electronic address: isatachi@iupui.edu.
² Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA.
³ Department of Statistics, Indiana University, Indianapolis, IN, USA.
⁴ Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, IN, USA.

No abstract available

Publication types